Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study
Launched by UNIVERSITY OF SASKATCHEWAN · Apr 24, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the possibility of using Pasteurized Donor Human Milk (PDHM) for infants who have been exposed to HIV. PDHM is human milk that has been safely processed to kill any harmful germs while keeping its beneficial nutrients. The goal of this study is to see if feeding PDHM to HIV-exposed infants is a practical option and to understand any challenges that caregivers might face in using this milk. This research is important because it could provide a safer alternative to formula feeding, which is currently the standard for these infants.
To participate in this trial, you need to be at least 15 years old, either pregnant or a new parent living with HIV, and be the primary caregiver of an HIV-exposed infant. You should live near Saskatoon and have access to a household freezer. If you join, you can expect to provide feedback on your experience with PDHM and help researchers understand how to make this feeding option more accessible. The findings from this study could lead to better support for families in similar situations in the future.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • ≥15 years of age
- • Pregnant or recently gave birth and living with HIV or is the primary caregivers of an HIV-exposed infant
- • Being followed by SHA Pediatric Infectious Disease
- • Saskatoon resident (living within \~25 km from the University of Saskatchewan)
- • Have a household freezer
- • Willing to participate
About University Of Saskatchewan
The University of Saskatchewan is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a commitment to improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. By fostering collaborations among researchers, healthcare professionals, and industry partners, the University of Saskatchewan aims to translate scientific discoveries into practical applications that enhance healthcare delivery and contribute to the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Patients applied
Trial Officials
Kelsey M Cochrane, PhD
Principal Investigator
University of Saskatchewan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported